MoU between India & Suriname
On August 16, 2023 it was announced that a Memorandum of Understanding (MoU) was signed on in June, 2023 between the Indian Pharmacopoeia Commission (IPC), Ministry of Health & Family Welfare, Government of India and Ministry of Health, Government of the Republic of Suriname for Recognition of Indian Pharmacopoeia (IP) in Suriname.
About the MoU
- MoU: for Recognition of Indian Pharmacopoeia (IP) in Suriname
- Signed between: Indian Pharmacopoeia Commission (IPC), Ministry of Health & Family Welfare, Government of India and Ministry of Health, Government of the Republic of Suriname
- Signed on: June 4, 2023
What is the Indian Pharmacopoeia Commission (IPC)?
- The Indian Pharmacopoeia Commission (IPC) operates under the Ministry of Health and Family Welfare.
- IPC establishes and updates drug standards in India, focusing on prevalent diseases.
- It publishes the Indian Pharmacopoeia (IP) as the official document for setting quality standards.
- The Indian Pharmacopocia (IP) is officially recognized by five (5) countries: Afghanistan, Ghana, Nepal, Maunnus and the Republic of Suriname.